{"transactions":[{"id":1822625,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-07-26T18:12:22.000Z","date":"2023-07-24","kind":"other","planned":false,"acquired":false,"shares":896058,"price":0.3,"value":268817.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 29, 2023, by and among GreenLight Biosciences Holdings, PBC (\"Issuer\"), SW ParentCo, Inc. (\"Parent\"), and SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), to which Merger Sub completed a tender offer for shares of common stock of the Issuer, $0.0001 par value per share (each, a \"Share\"), and thereafter merged with and into the Issuer effective as of July 24, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $0.30 per Share, in cash, without interest  and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 29, 2023, by and among GreenLight Biosciences Holdings, PBC (\"Issuer\"), SW ParentCo, Inc. (\"Parent\"), and SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), to which Merger Sub completed a tender offer for shares of common stock of the Issuer, $0.0001 par value per share (each, a \"Share\"), and thereafter merged with and into the Issuer effective as of July 24, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $0.30 per Share, in cash, without interest  and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-034844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000095017023034844/ownership.xml","form_type":"4"}},{"id":2411297,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":292649,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares underlying the option vested or shall vest after one year of service and the remainder of the shares vested or shall vest in 36 equal monthly installments."}],"balance_after":292649,"derivative":{"exercise_price":0.98,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":292649},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411296,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":1906944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares underlying the option vested or shall vest on December 1, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting January 1, 2022."}],"balance_after":1906944,"derivative":{"exercise_price":0.98,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":1906944},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411295,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":668830,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021."}],"balance_after":668830,"derivative":{"exercise_price":0.5,"expiration_date":"2029-12-29","underlying":"Common Stock","underlying_shares":668830},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411294,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":1982609,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"20% of the shares underlying the option vested or shall vest on December 5, 2020 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting December 5, 2021."}],"balance_after":1982609,"derivative":{"exercise_price":0.5,"expiration_date":"2029-12-29","underlying":"Common Stock","underlying_shares":1982609},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411293,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":926330,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"20% of the shares underlying the option vested or shall vest on September 12, 2018 and the remainder of the shares vested or shall vest in 48 equal monthly installments thereafter, starting October 12, 2018."}],"balance_after":926330,"derivative":{"exercise_price":0.33,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":926330},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411292,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":70319,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was issued pursuant to the terms of a business combination agreement involving the Issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":70319,"derivative":{"exercise_price":0.35,"expiration_date":"2023-07-29","underlying":"Common Stock","underlying_shares":70319},"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":2411291,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-04T19:26:38.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":896058,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company."}],"balance_after":896058,"source":{"system":"sec-edgar","filing":"0001062993-22-002726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727404/000106299322002726/form4.xml","form_type":"4"}},{"id":3323448,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-01-03T21:31:50.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 2, 2020 and vests in full on December 31, 2020."}],"balance_after":10000,"derivative":{"exercise_price":4.43,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-000997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120000997/doc4.xml","form_type":"4"}},{"id":3489727,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-06-14T20:17:14.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 13, 2019 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":10000,"derivative":{"exercise_price":5.26,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919119037130/doc4.xml","form_type":"4"}},{"id":3531653,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:05:20.000Z","date":"2019-05-08","kind":"sale","acquired":false,"shares":8000,"price":10.0049,"value":80039.2,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form."}],"balance_after":10189,"source":{"system":"sec-edgar","filing":"0000899243-19-013080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319013080/doc4.xml","form_type":"4"}},{"id":3709234,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-01-03T21:05:30.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 2, 2019 and vests in four equal consecutive annual installments beginning January 2, 2020."}],"balance_after":100000,"derivative":{"exercise_price":28.92,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319000269/doc4.xml","form_type":"4"}},{"id":3709233,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-01-03T21:05:30.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 2, 2019 and vests in full on the one year anniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":28.92,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319000269/doc4.xml","form_type":"4"}},{"id":3729329,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-12-17T21:08:22.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 13, 2018 and vests in full on the earlier to occur of the one year anniversary of the grant date and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and  will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":10000,"derivative":{"exercise_price":23.58,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-031207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318031207/doc4.xml","form_type":"4"}},{"id":3756766,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":111114,"kind":"person","name":"Zarur Juan Andrey","position":1,"cik":"0001727404","reported_name":"Zarur Juan Andrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-20T11:30:36.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":100,"price":35,"value":3500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018."}],"balance_after":691105,"source":{"system":"sec-edgar","filing":"0000899243-18-029423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318029423/doc4.xml","form_type":"4"}}]}